Results 141 to 150 of about 333,932 (156)
Some of the next articles are maybe not open access.

Inhibition of the renin–angiotensin–aldosterone system

Journal of Hypertension, 2012
Antagonism of renin-angiotensin-aldosterone system is exerted through angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, renin inhibitors and mineralocorticoid receptor antagonists. These drugs have been successfully tested in numerous trials and in different clinical settings.
VOLPE, Massimo   +6 more
openaire   +3 more sources

The cardiorenal continuum: a focus on iron deficiency, arrhythmia [PDF]

open access: possible, 2017
Heart failure remains a leading cause of hospitalisation in the developed world. Comorbidities such as iron deficiency and chronic kidney disease (CKD) pose management challenges and have been proven to have prognostic impact. The link between cardiac and renal disease is complex and is now understood to begin before abnormalities in either system ...
openaire  

Contemporary Therapeutic Approaches in the Cardiorenal-Metabolic Continuum: Current Perspectives on Diabetes, Chronic Kidney Disease, and Cardiovascular Dysfunction

International Science Journal
Cardiorenal syndrome associated with type 2 diabetes mellitus has emerged as a major global health challenge due to its increasing prevalence, complex pathophysiology, and significant impact on morbidity and mortality. The interaction between cardiovascular disease, chronic kidney disease, and metabolic dysfunction creates a bidirectional cycle of ...
null Santiago Ávila Ak   +7 more
openaire   +1 more source

Patient Navigation Across the Cancer Care Continuum: An Overview of Systematic Reviews and Emerging Literature

Ca-A Cancer Journal for Clinicians, 2023
Dorothy Keefe   +2 more
exaly  

Biomarker-Guided Pharmacotherapy Across the Ckm Continuum: From Subclinical Inflammation to Established Cardiorenal Disease

Cardiovascular–kidney–metabolic (CKM) syndrome is a progressive disorder driven by the interplay of metabolic dysfunction, chronic inflammation, cardiovascular disease, and chronic kidney disease. Biomarker-guided pharmacotherapy has emerged as a promising approach for early diagnosis, risk stratification, and personalized treatment across the CKM ...
openaire   +1 more source

Protective Effects of SGLT-2 Inhibitors Across the Cardiorenal Continuum: Two Faces of the Same Coin

European Journal of Preventive Cardiology, 2022
Frank Ruschitzka   +2 more
exaly  

Weight Management and Physical Activity Throughout the Cancer Care Continuum

Ca-A Cancer Journal for Clinicians, 2018
Wendy Demark-Wahnefried   +2 more
exaly  

The Affordable Care Act and Access to Care Across the Cancer Control Continuum: A Review at 10 Years

Ca-A Cancer Journal for Clinicians, 2020
Leticia Nogueira   +2 more
exaly  

Home - About - Disclaimer - Privacy